www.sicor.ltAbout usDivisionsSales and Marketing Department Print

Sales and Marketing Department

To strengthen the operations by Teva Corporation in new markets and unify the control over the three companies in the Baltics, Sicor Biotech UAB, the largest biotech medicine producer in the Baltics, and Latvian and Estonian offices of Teva and Ivax companies have merged into Teva Baltic division in early 2007. Teva Baltics currently consists of the Lithuanian Sales and Marketing Department of Sicor Biotech and Sicor Biotech branches in Latvia and Estonia.

Extensive experience in the field of biotechnology acquired by Sicor Biotech and its efficient resource management system is also being implemented in the joint operations of Teva Baltic division. Sicor Biotech has assumed the role of the importer and distributor of Teva production in the second Central and Eastern European region including the Baltics.

Focusing on specific markets and introducing the Teva brand, the Teva Baltics division does not hide its ambitious goal to become a leader in the Baltics.

Report an adverse   reaction to medicine

We work to keep our products safe. Please report any suspected adverse reactions. Report us

Last news

All news